Key Market Players Discuss Strategies for Success in the In Vitro Protein Expression Market

The In Vitro Protein Expression Market is anticipated to reach a value of US$ 428.8 million by 2034, with a projected Compound Annual Growth Rate (CAGR) of 6.1% from 2024 to 2034. This growth is attributed to the increasing demand for recombinant proteins in research and diagnostics worldwide. In 2024, the market is estimated to be US$ 238.2 million. The In Vitro Protein Expression Market is a segment of the biotechnology industry that focuses on producing proteins outside of living cells, offering several advantages over traditional in vivo protein expression methods. This market is driven by the increasing demand for recombinant proteins in various applications, including drug development, diagnostics, and research.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9563

Market Dynamics:

The market is primarily driven by the rising demand for recombinant proteins in pharmaceutical and biotechnology industries. In vitro protein expression offers advantages such as cost-effectiveness, rapid production, and the ability to express complex proteins that are difficult to produce in vivo. Additionally, the growing investments in research and development activities and the increasing number of biotechnology and pharmaceutical companies are contributing to market growth.

Market Future Outlook:

The in vitro protein expression market is expected to continue growing due to advancements in protein expression technologies, increasing research activities in proteomics and genomics, and the rising demand for personalized medicine. The market is also likely to benefit from the development of high-throughput technologies and the growing adoption of in vitro diagnostics.

Market Insights:

The market is segmented based on expression systems, including prokaryotic expression systems, mammalian cell expression systems, insect cell expression systems, yeast expression systems, and cell-free expression systems. Among these, the prokaryotic expression systems segment is expected to dominate the market due to their cost-effectiveness and high expression levels. However, the mammalian cell expression systems segment is anticipated to witness significant growth owing to their ability to produce complex proteins with proper post-translational modifications.

Key Players:

Thermo Fisher Scientific
Lonza Group
Merck Group (Merck KGaA)
Genscript Biotech Corporation
Bio-Rad Laboratories
Agilent Technologies
Promega Corporation
New England Biolabs (NEB)
Qiagen
Genentech (Roche)
Novartis
Amgen
Biogen
Pfizer
AstraZeneca
GlaxoSmithKline (GSK)
Vertex Pharmaceuticals
Charles River Laboratories
Abcam
Sartorius AG

Competitive Landscape:

The global in vitro protein expression market is primarily driven by ongoing innovations in gene therapy and advanced biopharmaceutical research. Major players in this industry are investing significant amounts in developing new technologies. These companies often collaborate with research institutes and academia to enhance their capabilities, leading to knowledge exchange and technological advancements within the scientific community.

For example, in October 2023, Taysha Gene Therapies presented compelling preclinical in vitro data on TSHA-102 in Rett Syndrome at the European Society of Gene & Cell Therapy Congress, highlighting the support for miRARE regulation of MECP2 expression.

Another key player, Swiss-based Lonza Group, has expanded its early development services to North America with a new laboratory in Cambridge, Massachusetts. This expansion is aimed at supporting US biotechs in the commercialization of novel therapies.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=9563

In Vitro Protein Expression Market - Segmentation

By Product Type:

E.coli Cell-Free Protein Expression System

Rabbit Reticulocytes Cell-Free Protein Expression System

Wheat Germ Cell-Free Protein Expression System

Insect Cells Cell-Free Protein Expression System

Mammalian Cell-Free Protein Expression System

By Application:

Protein Labeling

Protein-Protein Interaction

Protein Purification

Continuous Flow Expression

By Expression Mode:

Continuous Flow Expression

Batch Expression

By End User:

Biotechnological Companies

Pharmaceutical Companies

Contract Research Organizations

Academic and Research Institutes

By Region:

North America

Latin America

Europe

Asia Pacific

Middle East & Africa (MEA)

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.